Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Obesity-related conditions

Clinical impact of obesity on thyroidectomy outcomes: A systematic review and meta-analysis

Ghani A, Al Darwashi LM, Hajeir MY, Ayesh AR, Witkowiak MM, Alogakos M, Hage K, Than CA, Nakanishi H, Shin J, Romero-Velez G. Clinical impact of obesity on thyroidectomy outcomes: A systematic review and meta-analysis Surgery

Maternal adiposity and inflammation: risk factors for iron deficiency in pregnancy

Demirdjian SP, Mulhern MS, Kerr MA, Ledwidge M, Alhomaid RM, Thompson PD, McCann MT. Maternal adiposity and inflammation: risk factors for iron deficiency in pregnancy The Journal of Nutrition

Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study

Artime E, Spaepen E, Zimner-Rapuch S, Lampropoulou A, Adam A, Lin X, Shang M, Seager S, Le Roux CW, Dicker D. Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study Advances in Therapy

It Is a Vicious Circle: Experiences of People Living With Obesity and Chronic Pain: A Qualitative Evidence Synthesis (QES)

Hinwood NS, Casey MB, Dunlevy CG, Doody C, Blake C, Fullen BM, O'Donoghue G, Birney S, Fildes F, Smart KM. It Is a Vicious Circle: Experiences of People Living With Obesity and Chronic Pain: A Qualitative Evidence Synthesis (QES) Obes Rev

Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Davies MJ, Bajaj HS, Broholm C, Eliasen A, Garvey WT, le Roux CW, Lingvay I, Lyndgaard CB, Rosenstock J, Pedersen SD; REDEFINE 2 Study Group. Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes N Engl J Med
Insulin Resistance & Diabetes

Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study)

Al-Najim W, Dehestani B, Al-Humadi AW, Bodicoat DH, Papamargaritis D, Lean M, McGowan B, Webb DR, Wilding JP, Davies MJ, le Roux CW. Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study) Metabolites

Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide

Linetzky B, Sattar N, Verma S, Krumholz HM, Xie CC, Hoffmann HT, Zimner-Rapuch S, Torcello-Gómez A, Stefanski A. Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide Ann Intern Med

Peritoneal dialysis catheter insertion in patients with obesity: a cohort study and single centre approach to increasing uptake

Andrew W, Michael C, Daniel C, James M, Damian M, Damian F, Stephen O. Peritoneal dialysis catheter insertion in patients with obesity: a cohort study and single centre approach to increasing uptake BMC Nephrol
Chronic Kidney Disease

Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis

Pan XH, Tan B, Chin YH, Lee ECZ, Kong G, Chong B, Kueh M, Khoo CM, Mehta A, Majety P, Grandhi GR, Dimitriadis GK, Foo R, Chew NWS, Le Roux CW, Mamas MA, Chan MY. Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis Obesity (Silver Spring)

Perspectives on the profiling of renal risk in obesity

Docherty NG. Perspectives on the profiling of renal risk in obesity Panminerva Medica
Chronic Kidney Disease

Older posts

Newer posts

← Previous Page1 Page2 Page3 … Page25 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI